Canada markets closed

Biofrontera Inc. (BFRI)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
1.6700-0.0400 (-2.34%)
At close: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 8.91M
Enterprise Value 12.89M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.08
Price/Book (mrq)1.86
Enterprise Value/Revenue 0.38
Enterprise Value/EBITDA -0.70

Trading Information

Stock Price History

Beta (5Y Monthly) 0.84
52-Week Change 3-86.64%
S&P500 52-Week Change 321.23%
52 Week High 313.4200
52 Week Low 30.6100
50-Day Moving Average 31.2872
200-Day Moving Average 34.9410

Share Statistics

Avg Vol (3 month) 3791.72k
Avg Vol (10 day) 3105.08k
Shares Outstanding 55.09M
Implied Shares Outstanding 65.09M
Float 82M
% Held by Insiders 128.19%
% Held by Institutions 139.15%
Shares Short (Mar 28, 2024) 434.77k
Short Ratio (Mar 28, 2024) 40.21
Short % of Float (Mar 28, 2024) 40.68%
Short % of Shares Outstanding (Mar 28, 2024) 40.68%
Shares Short (prior month Feb 29, 2024) 4110.27k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jul 05, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -59.08%
Operating Margin (ttm)-36.48%

Management Effectiveness

Return on Assets (ttm)-33.86%
Return on Equity (ttm)-140.43%

Income Statement

Revenue (ttm)34.07M
Revenue Per Share (ttm)22.03
Quarterly Revenue Growth (yoy)4.50%
Gross Profit (ttm)N/A
EBITDA -20.85M
Net Income Avi to Common (ttm)-20.13M
Diluted EPS (ttm)-13.0200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.42M
Total Cash Per Share (mrq)0.28
Total Debt (mrq)5.4M
Total Debt/Equity (mrq)112.64%
Current Ratio (mrq)1.28
Book Value Per Share (mrq)3.16

Cash Flow Statement

Operating Cash Flow (ttm)-24.89M
Levered Free Cash Flow (ttm)-24.79M